IL4 and cholangiocarcinoma: In contrast to the data in HCC-Ova, Ova-specific IL-4 responses were increased in LmAI and LmAIO compared to Ova and PBS groups in a dose-dependent manner in CCA-Ova (Supplementary Fig. S6C, D).